--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About ADPT20260417C15
Life Science Tools and Services
Adaptive Biotechnologies Corporation was incorporated in Washington State on September 8, 2009. The company is advancing the field of immune-driven medicine by leveraging the inherent biology of the adaptive immune system to transform the diagnosis and treatment of diseases. The company believes that the adaptive immune system is nature's most sophisticated diagnosis and treatment for most diseases, but the inability to decode it prevents the medical community from taking full advantage of its capabilities. The company's immunomedicine platform applies proprietary technology to read multiple genetic codes of a patient's immune system and understand exactly how to detect and treat that patient's disease. The company's immunomedicine platform applies proprietary technology to read multiple genetic codes of a patient's immune system and understand exactly how to detect and treat that patient's disease. The company captures these insights in the Dynamic Clinical Immunomics Database, which is based on computational biology and machine learning for the development and commercialization of clinical products and services that companies are tailoring to each patient.
